Peer-reviewed articles

Rossi S, Baili P, Capocaccia R, et al. The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods. European Journal of Cancer. 2015;51(15):2104-2119. doi:10.1016/j.ejca.2015.08.001

Marcos-Gragera R, Mallone S, Kiemeney LA, et al. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. European Journal of Cancer. 2015;51(15):2217-2230. doi:10.1016/j.ejca.2015.07.028

Lepage C, Capocaccia R, Hackl M, et al. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5. European Journal of Cancer. 2015;51(15):2169-2178. doi:10.1016/j.ejca.2015.07.034

Holleczek B, Rossi S, Domenic A, et al. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2158-2168. doi:10.1016/j.ejca.2015.07.024

Gatta G, Botta L, Sánchez MJ, et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. European Journal of Cancer. 2015;51(15):2130-2143. doi:10.1016/j.ejca.2015.07.043

Francisci S, Minicozzi P, Pierannunzio D, et al. Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2242-2253. doi:10.1016/j.ejca.2015.07.033

De Angelis R, Minicozzi P, Sant M, et al. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study. European Journal of Cancer. 2015;51(15):2254-2268. doi:10.1016/j.ejca.2015.08.003

Crocetti E, Mallone S, Robsahm TE, et al. Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2179-2190. doi:10.1016/j.ejca.2015.07.039

Breckenridge K, Bekker HL, Gibbons E, et al. How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting. Nephrol Dial Transplant. 2015;30(10):1605-1614. doi:10.1093/ndt/gfv209

Baili P, Di Salvo F, Marcos-Gragera R, et al. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study. European Journal of Cancer. 2015;51(15):2120-2129. doi:10.1016/j.ejca.2015.07.025

Anderson LA, Tavilla A, Brenner H, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5. European Journal of Cancer. 2015;51(15):2144-2157. doi:10.1016/j.ejca.2015.07.026

O’Connor M, Waller J, Gallagher P, et al. Understanding Women’s Differing Experiences of Distress after Colposcopy: A Qualitative Interview Study. Women’s Health Issues. 2015;25(5):528-534. doi:10.1016/j.whi.2015.05.009

Pearce AM, Ryan F, Drummond FJ, Thomas AA, Timmons A, Sharp L. Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis. Support Care Cancer. Published online August 6, 2015:1-8. doi:10.1007/s00520-015-2857-8

Allemani C, Coleman MP. Cancer survival: the CONCORD-2 study – Authors’ reply. The Lancet. 2015;386(9992):429-430. doi:10.1016/S0140-6736(15)61443-X

Sharp L, Timmons A. Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors. Support Care Cancer. Published online July 5, 2015:1-11. doi:10.1007/s00520-015-2832-4

Sharp L, O’Leary E, Kinnear H, Gavin A, Drummond FJ. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study. Psycho-Oncology. 2015;25(3):282-291. doi:10.1002/pon.3909

O’Connor M, Gallagher P, Waller J, et al. Adverse psychological outcomes following colposcopy and related procedures: a systematic review. BJOG: Int J Obstet Gy. 2015;123(1):24-38. doi:10.1111/1471-0528.13462

Coebergh JW, van den Hurk C, Rosso S, et al. EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation. Eur J Cancer. 2015;51(9):997-1017. doi:10.1016/j.ejca.2015.02.018

Coebergh JW, van den Hurk C, Louwman M, et al. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits. Eur J Cancer. 2015;51(9):1050-1063. doi:10.1016/j.ejca.2015.02.017

Cahir C, Guinan E, Dombrowski SU, Sharp L, Bennett K. Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I-III breast cancer: A systematic review and meta-analysis. Patient Educ Couns. Published online May 30, 2015:S0738-3991(15)00234-7. doi:10.1016/j.pec.2015.05.013

Hanly P, Céilleachair AÓ, Skally M, O’Neill C, Sharp L. Direct costs of radiotherapy for rectal cancer: a microcosting study. BMC Health Serv Res. 2015;15:184. doi:10.1186/s12913-015-0845-9

O’Brien KM, Dwane F, Kelleher T, Sharp L, Comber H. Interval cancer rates in the Irish national breast screening programme. J Med Screen. Published online April 27, 2015. doi:10.1177/0969141315580386

O’Leary E, Drummond FJ, Gavin A, Kinnear H, Sharp L. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate’s egg. Qual Life Res. Published online March 20, 2015:1-12. doi:10.1007/s11136-015-0958-y

Barron TI, Murphy LM, Brown C, Bennett K, Visvanathan K, Sharp L. De-novo post-diagnosis aspirin use and mortality in women with stage I-III breast cancer. Cancer Epidemiol Biomarkers Prev. Published online March 19, 2015:cebp.1415.2014. doi:10.1158/1055-9965.EPI-14-1415

Dee A, Callinan A, Doherty E, et al. Overweight and obesity on the island of Ireland: an estimation of costs. BMJ Open. 2015;5(3):e006189. doi:10.1136/bmjopen-2014-006189